GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
39.12 -0.21  -0.55% NYSE Feb 10, 16:59 Delayed 2m USD

GlaxoSmithKline Enterprise Value:

117.27B for Feb. 9, 2016
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Enterprise Value Chart

Export Data
Save Image

GlaxoSmithKline Historical Enterprise Value Data

View and export this data going back to 1976. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Feb. 9, 2016 117.27B
Feb. 8, 2016 117.58B
Feb. 5, 2016 120.72B
Feb. 4, 2016 121.26B
Feb. 3, 2016 123.86B
Feb. 2, 2016 121.06B
Feb. 1, 2016 122.23B
Jan. 29, 2016 122.01B
Jan. 28, 2016 120.43B
Jan. 27, 2016 120.33B
Jan. 26, 2016 120.89B
Jan. 25, 2016 118.09B
Jan. 22, 2016 118.95B
Jan. 21, 2016 116.54B
Jan. 20, 2016 116.32B
Jan. 19, 2016 117.12B
Jan. 15, 2016 116.19B
Jan. 14, 2016 119.55B
Jan. 13, 2016 116.83B
Jan. 12, 2016 117.53B
Jan. 11, 2016 117.14B
Jan. 8, 2016 117.46B
Jan. 7, 2016 116.46B
Jan. 6, 2016 119.46B
Jan. 5, 2016 120.53B
   
Jan. 4, 2016 119.97B
Dec. 31, 2015 119.72B
Dec. 30, 2015 121.14B
Dec. 29, 2015 121.51B
Dec. 28, 2015 120.85B
Dec. 24, 2015 120.88B
Dec. 23, 2015 120.95B
Dec. 22, 2015 118.39B
Dec. 21, 2015 118.19B
Dec. 18, 2015 117.25B
Dec. 17, 2015 118.22B
Dec. 16, 2015 119.21B
Dec. 15, 2015 117.03B
Dec. 14, 2015 116.45B
Dec. 11, 2015 116.96B
Dec. 10, 2015 118.44B
Dec. 9, 2015 117.69B
Dec. 8, 2015 117.42B
Dec. 7, 2015 118.63B
Dec. 4, 2015 119.28B
Dec. 3, 2015 118.63B
Dec. 2, 2015 120.85B
Dec. 1, 2015 120.85B
Nov. 30, 2015 119.86B
Nov. 27, 2015 120.95B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

GSK Enterprise Value Benchmarks

Companies
Bristol-Myers Squibb 103.85B
Johnson & Johnson 264.59B
Merck & Co 152.00B

GSK Enterprise Value Range, Past 5 Years

Minimum 102.43B Sep 29 2015
Maximum 160.95B Apr 29 2014
Average 134.72B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.